Laboratory Credentialing Sample Clauses

The Laboratory Credentialing clause establishes the requirements and standards that laboratories must meet to be recognized or authorized under the agreement. Typically, this involves specifying necessary certifications, accreditations, or compliance with regulatory guidelines that laboratories must maintain to perform certain services or tests. By setting these criteria, the clause ensures that only qualified and competent laboratories are engaged, thereby safeguarding the quality and reliability of laboratory results and minimizing the risk of errors or non-compliance.
Laboratory Credentialing. 1. The ICO shall require all laboratories performing services under the three-way contract to comply with the Clinical Laboratory Improvement Amendments.
View SourceView Similar (3)
Laboratory Credentialing a. The CICO shall require all laboratories performing services under the Three-Way Contract to comply with the Clinical Laboratory Improvement Amendments.
View Source
Laboratory Credentialing. The Contractor shall require, in accordance with the Clinical Laboratory Improvement Amendments (CLIA), all laboratories performing services under this Contract to: a. Have a current, unrevoked or unsuspended certificate of waiver, registration certificate, certificate of compliance, certificate for PPM procedures, or certificate of accreditation issued by the U.S. Department of Health and Human Services applicable to the category of examinations or procedures performed by the laboratory; b. Be CLIA-exempt as defined in 42 CFR 493.2; or c. Satisfy an exception set forth in 42 CFR 493.3(b).
View Source

Related to Laboratory Credentialing

  • Credentialing Firm shall be required to access Citizens’ online vendor credentialing system (“CAIS”) to input, update and maintain certain information about Firm and the persons who will perform work related to this Agreement (“Staff”), as provided below and in Exhibit B attached hereto.

  • Benchmarking The Parties shall comply with the provisions of Framework Schedule 12 (Continuous Improvement and Benchmarking) in relation to the benchmarking of any or all of the Goods and/or Services.

  • Protocol The attached Protocol shall be an integral part of this Agreement.

  • Office of Inspector General Investigative Findings Expert Review In accordance with Senate Bill 799, Acts 2021, 87th Leg., R.S., if Texas Government Code, Section 531.102(m-1)(2) (eff. Apr. 1, 2025, Section 544.0106, pursuant to House Bill 4611, Acts 2023, 88th Leg., R.S.) is applicable to this Contract, Contractor affirms that it possesses the necessary occupational licenses and experience.

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.